Samuel Cohen researches Alzheimer's disease and other neurodegenerative disorders.
Why you should listen
Samuel Cohen is a Research Fellow in Biophysical Chemistry at St. John's College and the Centre for Misfolding Diseases in the Department of Chemistry at the University of Cambridge, from where he holds PhD, MSci, MA and BA degrees. Cohen has worked as a consultant in the London office of Boston Consulting Group (BCG), where he specialized in the healthcare, technology and media sectors. His scientific research focuses on neurodegenerative disorders. He is co-author of more than 20 scientific papers, book chapters and patents, and was recently a lead author on a widely-reported study in which researchers made a major breakthrough towards finding a cure for Alzheimer's disease.
